These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 32410589)
1. ADAR expression and copy number variation in patients with advanced gastric cancer. Behroozi J; Shahbazi S; Bakhtiarizadeh MR; Mahmoodzadeh H BMC Gastroenterol; 2020 May; 20(1):152. PubMed ID: 32410589 [TBL] [Abstract][Full Text] [Related]
2. Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme ADAR1 are important prognostic biomarkers in gastric cancer. Okugawa Y; Toiyama Y; Shigeyasu K; Yamamoto A; Shigemori T; Yin C; Ichikawa T; Yasuda H; Fujikawa H; Yoshiyama S; Hiro J; Ohi M; Araki T; Kusunoki M; Goel A J Transl Med; 2018 Dec; 16(1):366. PubMed ID: 30563560 [TBL] [Abstract][Full Text] [Related]
3. Bioinformatic analysis of the prognostic value of ZNF860 in recurrence-free survival and its potential regulative network in gastric cancer. Pan HX; Bai HS; Guo Y; Cheng ZY Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):162-170. PubMed ID: 30767193 [TBL] [Abstract][Full Text] [Related]
4. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer. Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725 [TBL] [Abstract][Full Text] [Related]
5. NOB1 Gene as a Potential Biomarker in Clinical Outcomes and Prognosis of Patients with Gastric Cancer. Qi H; Wang Y Clin Lab; 2018 Sep; 64(9):1469-1475. PubMed ID: 30274015 [TBL] [Abstract][Full Text] [Related]
6. Are PIK3CA Mutation and Amplification Associated with Clinicopathological Characteristics of Gastric Cancer? Lee H; Hwang IS; Choi IJ; Kang YN; Park KU; Lee JH Asian Pac J Cancer Prev; 2015; 16(11):4493-6. PubMed ID: 26107192 [TBL] [Abstract][Full Text] [Related]
7. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer. Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144 [TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis. Wang CY; Hua L; Yao KH; Chen JT; Zhang JJ; Hu JH Int J Clin Exp Pathol; 2015; 8(1):779-85. PubMed ID: 25755774 [TBL] [Abstract][Full Text] [Related]
9. Diversity of clinical implication of B-cell translocation gene 1 expression by histopathologic and anatomic subtypes of gastric cancer. Kanda M; Oya H; Nomoto S; Takami H; Shimizu D; Hashimoto R; Sueoka S; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y Dig Dis Sci; 2015 May; 60(5):1256-64. PubMed ID: 25487193 [TBL] [Abstract][Full Text] [Related]
10. Decreased expression of BRCA1-associated protein 1 predicts unfavorable survival in gastric adenocarcinoma. Yan S; He F; Luo R; Wu H; Huang M; Huang C; Li Y; Zhou Z Tumour Biol; 2016 May; 37(5):6125-33. PubMed ID: 26611647 [TBL] [Abstract][Full Text] [Related]
11. Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer. Mu YP; Tang S; Sun WJ; Gao WM; Wang M; Su XL Asian Pac J Cancer Prev; 2014; 15(20):8893-900. PubMed ID: 25374225 [TBL] [Abstract][Full Text] [Related]
12. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer. Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748 [TBL] [Abstract][Full Text] [Related]
13. AKR1B10, a good prognostic indicator in gastric cancer. Yao HB; Xu Y; Chen LG; Guan TP; Ma YY; He XJ; Xia YJ; Tao HQ; Shao QS Eur J Surg Oncol; 2014 Mar; 40(3):318-24. PubMed ID: 24406159 [TBL] [Abstract][Full Text] [Related]
14. Monitoring the HER2 copy number status in circulating tumor DNA by droplet digital PCR in patients with gastric cancer. Shoda K; Ichikawa D; Fujita Y; Masuda K; Hiramoto H; Hamada J; Arita T; Konishi H; Komatsu S; Shiozaki A; Kakihara N; Okamoto K; Taniguchi H; Imoto I; Otsuji E Gastric Cancer; 2017 Jan; 20(1):126-135. PubMed ID: 26874951 [TBL] [Abstract][Full Text] [Related]
15. Pituitary tumor-transforming gene-1 serves as an independent prognostic biomarker for gastric cancer. Xu MD; Dong L; Qi P; Weng WW; Shen XH; Ni SJ; Huang D; Tan C; Sheng WQ; Zhou XY; Du X Gastric Cancer; 2016 Jan; 19(1):107-15. PubMed ID: 25627474 [TBL] [Abstract][Full Text] [Related]
16. F11R RNA trinucleotide over-edited by ADAR in gastric and colorectal cancers: Cross-cohort validation, gene expression regulation, and diagnostic significance. Bao C; Feng JJ; Cui J; Guo T; He YS; Wei ZY; Qian CJ; Jin YY; Chen JH Biochem Biophys Res Commun; 2024 Sep; 726():150213. PubMed ID: 38964186 [TBL] [Abstract][Full Text] [Related]
17. Clinical and prognosis relevance of COX-2 expression in Tunisian patients with primary gastric adenocarcinoma. Ben Ayed-Guerfali D; Charfi S; Khabir A; Sellami-Boudawara T; Gargouri A; Mokdad-Gargouri R Cancer Biomark; 2016 Jun; 17(1):67-73. PubMed ID: 27314294 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of mixed lineage kinase domain-like protein expression in the survival of patients with gastric caner. Ertao Z; Jianhui C; Kang W; Zhijun Y; Hui W; Chuangqi C; Changjiang Q; Sile C; Yulong H; Shirong C Tumour Biol; 2016 Oct; 37(10):13679-13685. PubMed ID: 27473085 [TBL] [Abstract][Full Text] [Related]
19. Upregulation of microRNA-23a/b promotes tumor progression and confers poor prognosis in patients with gastric cancer. Ma G; Dai W; Sang A; Yang X; Gao C Int J Clin Exp Pathol; 2014; 7(12):8833-40. PubMed ID: 25674252 [TBL] [Abstract][Full Text] [Related]
20. FLAD1 is up-regulated in Gastric Cancer and is a potential prediction of prognosis. Hu P; Pan Y; Wang C; Zhang W; Huang H; Wang J; Zhang N Int J Med Sci; 2020; 17(12):1763-1772. PubMed ID: 32714079 [No Abstract] [Full Text] [Related] [Next] [New Search]